Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Herrera, Alex F
4006  Ergebnisse:
Personensuche X
?
1

Real-World Multicenter Study of PD-1 Blockade in HIV-Associ..:

Lurain, Kathryn ; Zarif, Talal El ; Ramaswami, Ramya...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Outcomes of Large B-Cell Lymphoma (LBCL) Patients with Seco..:

Hashmi, Hamza ; Epperla, Narendranath ; Ahn, Kwang...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S42 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Impact of Complete Response (CR) on Long-Term Survival Amon..:

Ghobadi, Armin ; Anagnostou, Theodora ; Azzi, Jacques...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S191-S192 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refracto..:

Mei, Matthew ; Tsai, Ni-Chun ; Palmer, Joycelynne...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
5

Comparison of whole‐genome and immunoglobulin‐based circula..:

Merryman, Reid W. ; Rhoades, Justin ; Xiong, Kan...
HemaSphere.  8 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
6

Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory..:

Driessen, Julia ; de Wit, Fer ; Herrera, Alex F....
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
7

CD19-Directed CART Therapy for T Cell/Histiocyte Rich Large..:

Fein, Dr. Joshua A ; Pophali, Priyanka A. ; Ahn, Kwang...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S356 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Advancing Inclusive Research (AIR) Site Alliance: Facilitat..:

Vidal, Gregory A. ; Chalela, Patricia ; Curry, Andrea N....
Contemporary Clinical Trials.  137 (2024)  - p. 107416 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Five-year follow-up of KEYNOTE-087: pembrolizumab monothera..:

Armand, Philippe ; Zinzani, Pier Luigi ; Lee, Hun Ju...
Blood.  142 (2023)  10 - p. 878-886 , 2023
Link: https://doi.org/10.1182/..
 
?
10

Cost‐effectiveness of polatuzumab vedotin in combination wi..:

Kambhampati, Swetha ; Shumilov, Evgenii ; Saumoy, Monica...
British Journal of Haematology.  202 (2023)  4 - p. 771-775 , 2023
Link: https://doi.org/10.1111/..
 
?
11

Minimal residual disease in patients with diffuse large B-c..:

Merryman, Reid W. ; Redd, Robert A. ; Taranto, Eleanor...
Blood Advances.  7 (2023)  17 - p. 4748-4759 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combi..:

Torka, Pallawi ; Kambhampati, Swetha ; Chen, Lu...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

P1098: A PHASE II, OPEN-LABEL, MULTICENTER STUDY OF CAPIVAS..:

Hodson, Daniel ; Shouse, Geoffrey ; Shin, Ho-Jin...
HemaSphere.  7 (2023)  S3 - p. e5749555 , 2023
Link: https://doi.org/10.1097/..
 
?
14

Adding venetoclax to lenalidomide and rituximab is safe and..:

Phillips, Tycel J. ; Bond, David ; Takiar, Radihka...
Blood Advances.  7 (2023)  16 - p. 4518-4527 , 2023
Link: https://doi.org/10.1182/..
 
?
15

Impact of early relapse within 24 months after first-line s..:

Epperla, Narendranath ; Welkie, Rina Li ; Torka, Pallawi...
Journal of Hematology & Oncology.  16 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
1-15